400
Participants
Start Date
July 1, 2016
Primary Completion Date
September 14, 2017
Study Completion Date
June 20, 2018
Decision aid for breast cancer screening
Women in the intervention arm will receive a leaflet with detailed information on the benefits (breast cancer mortality reduction, less intensive treatments) and harms (false positive results and overdiagnosis).
Standard leaflet
Women in the control arm will receive a standard leaflet that does not mention harms and recommends accepting the invitation to participate in the biennial exams of the EDBCP.
Lleida Biomedical Research Institute (IRBLLEIDA), Lleida
Hospital del Mar
OTHER
Canary Islands Health Service
UNKNOWN
Institut Català d'Oncologia
OTHER
Institut de Recerca Biomèdica de Lleida
OTHER